Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | VKORC1 | Q9BQB6 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2808497 | 0.85 | KDM4E (0.57) | ALDH1A1GLAKDM4ECA12CA9 | |
| SCHEMBL30776764 | 0.85 | KDM4E (0.57) | ALDH1A1GLAKDM4ECA12CA9 | |
| SCHEMBL2284198 | 0.81 | CA12 (0.71) | ALDH1A1GLAKDM4ECA12CA9 | |
| SCHEMBL6888225 | 0.80 | SRC (0.53) | ALDH1A1GLAKDM4ECA12CA9 | |
| SCHEMBL29801774 | 0.79 | ALDH1A1 (0.51) | ALDH1A1GLAKDM4ECA12CA9 | |
| SCHEMBL1719127 | 0.78 | HSD17B3 (0.36) | ALDH1A1GLAKDM4ECA12CA9 | |
| SCHEMBL1938437 | 0.78 | ALDH1A1 (0.77) | ALDH1A1GLAKDM4ECA12CA9 | |
| SCHEMBL2450078 | 0.78 | KDM4E (0.71) | ALDH1A1GLAKDM4ECA12CA9 | |
| SCHEMBL28335164 | 0.78 | ALDH1A1 (0.50) | ALDH1A1GLAKDM4ECA12CA9 | |
| Acetic Acid SCHEMBL15653002 | 0.77 | KDM4E (0.66) | ALDH1A1KDM4ECA12CA9SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0856065-B1 | ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE | UNIV NEBRASKA (US) | 2003-06-25 | — | — | EP | claimed |
| US-6130049-A | MEASURING ACTIVITY OF CATALYTIC ANTIBODIES BY CONTACTING PEPTIDE HAVING AT LEAST ONE ARGININE, LYSINE, OR PROLINE WITH TEST AND CONTROL SAMPLES AND PROMOTING CATALYTIC CLEAVAGE OF PEPTIDE; REDUCED ACTIVITY INDICATES DISEASE OR PREDISPOSITION | THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2000-10-10 | — | — | US | claimed |
| EP-0856065-A4 | ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE | UNIV NEBRASKA (US) | 2000-05-31 | — | — | EP | claimed |
| EP-0856065-A1 | ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-08-05 | — | — | EP | claimed |
| WO-1997004125-A1 | ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1997-02-06 | — | — | WO | claimed |
| JP-10099075-A | — | — | None | — | — | JP | disclosed |
| JP-4066085-A | — | — | None | — | — | JP | disclosed |
| WO-2025089217-A1 | COMPOUND FOR USE AS SUBSTRATE FOR EVALUATING ACTIVITY OF γ-D-GLUTAMYL-L-LYSYL ENDOPEPTIDASE | 株式会社ヤクルト本社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2024262350-A1 | PEPTIDE OR SALT THEREOF, COMPOSITION CONTAINING SAME, AND COMPOSITION FOR SUPPRESSING DECLINE OF OR IMPROVING COGNITIVE FUNCTIONS | サントリーホールディングス株式会社 | 2024-12-26 | — | — | WO | disclosed |
| WO-2024237199-A1 | PROPHYLACTIC/THERAPEUTIC AGENT FOR PREGNANCY-INDUCED HYPERTENSION | 国立大学法人金沢大学 | 2024-11-21 | — | — | WO | disclosed |
| WO-2024122520-A1 | METHOD, KIT AND DEVICE FOR DETECTING EXTRACELLULAR VESICLES | キヤノン株式会社 | 2024-06-13 | — | — | WO | disclosed |
| US-11712466-B2 | Vaccine composition | TOHOKU UNIVERSITY (JP) | 2023-08-01 | — | — | US | disclosed |
| EP-0570554-A4 | MONOCLONAL ANTIBODY AND ANTIBODY COMPONENTS ELICITED TO A POLYPEPTIDE ANTIGEN GROUND STATE | IGEN INC (US) | 1997-02-26 | — | — | EP | disclosed |
| US-5599538-A | CATALYZING THE HYDROLYSIS OF THE PEPTIDE BONDE BETWEEN AMINO ACID RESIDUES, E.G. THE VASOACTIVE INTESTINAL PEPTIDE; ANTICARCINOGENIC AGENTS; VIRICIDES; BACTERICIDES; PROTOZOA; MEDICAL DIAGNOSIS | IGEN, INC. (US) | 1997-02-04 | — | — | US | disclosed |
| EP-0699763-A1 | Nucleic acid sequence encoding trypsin-like enzyme and process for producing the enzyme | TEIJIN LIMITED (JP) | 1996-03-06 | — | — | EP | disclosed |
| WO-1995027496-A1 | VASOACTIVE INTESTINAL POLYPEPTIDE | PROTEINIX COMPANY (US) | 1995-10-19 | — | — | WO | disclosed |
| US-5318897-A | Catalytically cleaving a polypeptides | IGEN, INC. (US) | 1994-06-07 | — | — | US | disclosed |
| EP-0570554-A1 | MONOCLONAL ANTIBODY AND ANTIBODY COMPONENTS ELICITED TO A POLYPEPTIDE ANTIGEN GROUND STATE | IGEN, INC. (US) | 1993-11-24 | — | — | EP | disclosed |
| WO-1993009247-A1 | MONOCLONAL ANTIBODY AND ANTIBODY COMPONENTS ELICITED TO A POLYPEPTIDE ANTIGEN GROUND STATE | IGEN, INC. (US) | 1993-05-13 | — | — | WO | disclosed |
| JP-H0466085-A | PROLYL ENDOPERPTIDASE AND PRODUCTION THEREOF | YAKULT HONSHA CO LTD | 1992-03-02 | — | — | JP | disclosed |